激活STING和ICD双响应全瘤细胞疫苗增强了TNBC免疫疗法
Zhuoting Lu1, Weijie Gu1, Fangping Jiang1
1College of Biotechnology and Bioengineering, Zhejiang University of Technology, Hangzhou, 310032, China.
Biomaterials
|March 5, 2026
概括
这项研究介绍了一种使用纳米粒子介导光化疗的新型全瘤细胞疫苗 (TCV) 平台. 这种方法有效地激活了抗瘤免疫力,提高了癌症免疫治疗结果.
科学领域:
- 免疫学 免疫学 免疫学
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
背景情况:
- 有效的癌症免疫疗法需要精确控制瘤特异性免疫反应.
- 全瘤细胞疫苗 (TCV) 提供广泛的抗原谱,但在定制免疫激活方面面临挑战.
研究的目的:
- 开发一个TCV平台,使用纳米粒子介导的光化疗来进行空间时间控制的免疫激活.
- 通过利用近红外 (NIR) 激光照射来提高TCV的疗效,以促进协同免疫刺激.
主要方法:
- 使用纳米粒子和NIR激光照射生成一种免疫性光化疗衍生的TCV (IPL-TCV).
- 激活干扰素基因刺激器 (STING) 途径和诱导免疫细胞死亡 (ICD).
- 评估免疫细胞的招募,成熟和T细胞激活,包括树突细胞 (DC).
主要成果:
- IPL-TCV平台成功激活了STING通路和ICD,扩大了TCV抗原谱.
- 尼尔射线激光照射协同增强了先天性和适应性免疫力,导致了强大的抗瘤反应.
- 该策略在减少瘤生长和通过促进DC和T细胞激活来预防瘤复发方面表现出显著的有效性.
结论:
- 光化疗协调的TCV策略通过空间时间定制的免疫刺激来增强癌症免疫疗法.
- 这种个性化的TCV方法显示了增强对瘤的先天性和适应性免疫力的前景.
- 开发的平台提供了一种新的方法,用于生成有效的全瘤细胞疫苗,以改善输送和免疫激活.
更多相关视频
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.8K
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
15.3K
相关概念视频
Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
